Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada

被引:19
作者
Higgins, Rachel R. [1 ]
Eshaghi, A. [1 ]
Burton, L. [1 ]
Mazzulli, T. [1 ,2 ,3 ]
Drews, S. J. [1 ,2 ,3 ]
机构
[1] Cent Publ Hlth Lab, Toronto, ON, Canada
[2] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Dept Pathobiol & Lab Med, Toronto, ON, Canada
关键词
Influenza A; Amantadine; Resistance; Oseltamivir; VIRUSES; SEASON;
D O I
10.1016/j.jcv.2008.10.001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Molecular methods were used to characterize influenza A (H1N1) and (H3N2) strains and to identify amantadine-resistance. Objectives: To compare proportions of amantadine-resistant influenza A (H1N1) and (H3N2) isolates in the Greater Toronto Area. Study design: Isolates Of influenza A (H1N1) and (H3N2) were strain typed using molecular methods. Pyrosequencing for point mutations in the transmembrane domain of the M2 proton channel was undertaken. Proportions of amantadine-resistant and Susceptible isolates were compared using the The Fisher's exact test. Results: 96% of the 49 influenza A (H3N2) isolates and none of the influenza A (H I NI) tested carried a point mutation in the M gene coding for the M2 protein. Influenza A (H3N2) isolates were more likely to carry an amantadine-resistance associated mutation than influenza A (H1N1) isolates (Fishers's exact test. P < 0.0001). Conclusions: : Characterization of amantadine-resistance in influenza A (H1N1) isolates should utilize a variety of different methods including sub-typing, strain typing, and direct sequencing for point Mutations associated with amantadine-resistance. Crown Copyright (c) 2008 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 93
页数:3
相关论文
共 9 条
  • [1] BARR IG, 2008, ANTIVIRAL RES
  • [2] Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States
    Bright, RA
    Shay, DK
    Shu, B
    Cox, NJ
    Klimov, AI
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (08): : 891 - 894
  • [3] Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44
  • [4] Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide
    Deyde, Varough M.
    Xu, Xiyan
    Bright, Rick A.
    Shaw, Michael
    Smith, Catherine B.
    Zhang, Ye
    Shu, Yuelong
    Gubareva, Larisa V.
    Cox, Nancy J.
    Klimov, Alexander I.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (02) : 249 - 257
  • [5] Hata M, 2007, JPN J INFECT DIS, V60, P202
  • [6] Kawai Naoki, 2007, Journal of Infection and Chemotherapy, V13, P314, DOI 10.1007/s10156-007-0538-3
  • [7] Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples
    Schweiger, B
    Zadow, I
    Heckler, R
    Timm, H
    Pauli, G
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) : 1552 - 1558
  • [8] Recurrence and persistence of fever in children who developed amantadine-resistant influenza viruses after treatment
    Shobugawa, Yugo
    Saito, Reiko
    Sato, Isamu
    Li, Danjuan
    Suzuki, Yasushi
    Sasaki, Asami
    Sato, Maki
    Suzuki, Hiroshi
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 214 (02) : 129 - 138
  • [9] Fatal oseltamivir-resistant influenza virus infection
    van der Vries, Erhard
    van den Berg, Bart
    Schutten, Martin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (10) : 1074 - 1076